Regularly monitoring key biomarkers is non-negotiable
Individuals engaging in unstructured reduced dietary intake while on GLP-1 RAs should be monitored for gut microbiome diversity, as preserved diversity is critical for maintaining the anti-inflammatory effects associated with a healthy microbiome
GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), are pharmaceutical drugs that mimic a naturally occurring gut hormone called glucagon-like peptide-1
The protocol guides handle the strategy
Curr Opin Investig Drugs 11:440446 Yazbeck R, Sulda ML, Howarth GS, Bleich A, Raber K, von Hrsten S, Holst JJ, Abbott CA (2010b) Dipeptidyl peptidase expression during experimental colitis in mice
Both ileus and bowel obstruction are medical emergencies